Arabic Translation and Validation of the Clinician Administered Staden Schizophrenia Anxiety Rating Scale (S-SARS)

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Nov 18

PMID 39553570

Authors

Feten Fekih-Romdhane

Fadila Al Mouzakzak

Ghinwa Abilmona

Ahmed Moustafa

Oussama Dahdouh

Souheil Hallit

Affiliations

Soon will be listed here.

Abstract

Background: Research on anxiety in patients with schizophrenia of Arab origin is surprisingly scarce, particularly given that expressions of both psychotic disorders and anxiety disorders can be largely shaped by cultural factors. This study proposes to complement previous research by exploring the psychometric characteristics of an Arabic translation of the Staden Schizophrenia Anxiety Rating Scale (S-SARS) in chronic, remitted patients diagnosed with schizophrenia. As the Arabic version of the Generalized Anxiety Disorder 7-Item Scale (GAD-7) has not been previously validated in Arabic in patients with schizophrenia, this study had as a secondary aim to investigate the psychometric properties of this scale before its use.

Method: This cross-sectional study was performed over a period of three months (August-October 2023). A total of 177 chronic inpatients diagnosed with schizophrenia (63.3 % males) who were remitted and clinically stable participated in the study.

Results: Confirmatory factor analyses showed that all 10 items loaded onto a single factor and had high factor loading values between .53 and .81. The reliability of the S-SARS in its Arabic version was excellent as attested by a McDonald's omega and a Cronbach's alpha coefficients of .90 and .89, respectively. The score of Arabic S-SARS correlated positively with the GAD-7 scores (r = .55; p < .001), thus supporting good convergent validity. As for discriminant validity, findings showed positive correlations between S-SARS and depression scores as assessed using the Calgary Depressive Symptoms Scale. In addition, the Arabic S-SARS correlated negatively with general functioning, further supporting the good validity and clinical relevance of the scale. Finally, measurement invariance was established in the sex subsamples (males vs. females) at the scalar, metric and configural levels, with females showing more anxiety than males.

Conclusion: Findings suggest that the Arabic S-SARS holds good psychometric properties, and is suitable for use among Arabic-speaking people diagnosed with schizophrenia in both research and clinical practice. The Arabic version of S-SARS will hopefully be widely applied to provide useful and timely clinical information for monitoring and adequately treating patients with schizophrenia, in order to improve the course and prognosis of the disease.

Citing Articles

Validation and optimal cut-off score of the World Health Organization Well-being Index (WHO-5) as a screening tool for depression among patients with schizophrenia.

Fekih-Romdhane F, Al Mouzakzak F, Abilmona G, Dahdouh O, Hallit S BMC Psychiatry. 2024; 24(1):391.

PMID: 38783217 PMC: 11112932. DOI: 10.1186/s12888-024-05814-z.

References

Seedat S, Fritelli V, Oosthuizen P, Emsley R, Stein D . Measuring anxiety in patients with schizophrenia. J Nerv Ment Dis. 2007; 195(4):320-4. DOI: 10.1097/01.nmd.0000253782.47140.ac. View

Hofmann S, Hinton D . Cross-cultural aspects of anxiety disorders. Curr Psychiatry Rep. 2014; 16(6):450. PMC: 4037698. DOI: 10.1007/s11920-014-0450-3. View

Achim A, Ouellet R, Lavoie M, Vallieres C, Jackson P, Roy M . Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders. Schizophr Res. 2013; 145(1-3):75-81. DOI: 10.1016/j.schres.2013.01.012. View

Howland R, Rush A, Wisniewski S, Trivedi M, Warden D, Fava M . Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2008; 99(1-3):248-60. DOI: 10.1016/j.drugalcdep.2008.08.010. View

Beaton D, Bombardier C, Guillemin F, Ferraz M . Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000; 25(24):3186-91. DOI: 10.1097/00007632-200012150-00014. View

Llorca P, Lancon C, Blanc O, De Chazeron I, Samalin L, Caci H . A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). Eur Arch Psychiatry Clin Neurosci. 2013; 264(2):171-8. DOI: 10.1007/s00406-013-0416-1. View

Beainy C, Haddad C, Fekih-Romdhane F, Hallit S, Haddad G . Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study. BMC Psychiatry. 2023; 23(1):222. PMC: 10069113. DOI: 10.1186/s12888-023-04711-1. View

Bayle F, Krebs M, Epelbaum C, Levy D, Hardy P . Clinical features of panic attacks in schizophrenia. Eur Psychiatry. 2001; 16(6):349-53. DOI: 10.1016/s0924-9338(01)00590-9. View

Kiran C, Chaudhury S . Prevalence of comorbid anxiety disorders in schizophrenia. Ind Psychiatry J. 2017; 25(1):35-40. PMC: 5248417. DOI: 10.4103/0972-6748.196045. View

10.

Priebe S, McCabe R, Junghan U, Kallert T, Ruggeri M, Slade M . Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011; 133(1-3):17-21. DOI: 10.1016/j.schres.2011.09.021. View

11.

Vesga-Lopez O, Schneier F, Wang S, Heimberg R, Liu S, Hasin D . Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2009; 69(10):1606-16. PMC: 4765378. View

12.

Naidu K, Van Staden W, Fletcher L . Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia. Ann Gen Psychiatry. 2020; 19:26. PMC: 7158120. DOI: 10.1186/s12991-020-00277-4. View

13.

Lovibond P, LOVIBOND S . The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995; 33(3):335-43. DOI: 10.1016/0005-7967(94)00075-u. View

14.

McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008; 30:67-76. DOI: 10.1093/epirev/mxn001. View

15.

Du C, Chen J, Ma X, Tu W, Chen L, Liu J . Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale. Front Psychiatry. 2022; 13:992745. PMC: 9530193. DOI: 10.3389/fpsyt.2022.992745. View

16.

Zhang B, Han M, Tan S, Yang F, Tan Y, Jiang S . Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients. Sci Rep. 2017; 7(1):11821. PMC: 5605539. DOI: 10.1038/s41598-017-12027-w. View

17.

Smith E, Garety P, Harding H, Hardy A . Are there reliable and valid measures of anxiety for people with psychosis? A systematic review of psychometric properties. Psychol Psychother. 2019; 94(1):173-198. DOI: 10.1111/papt.12265. View

18.

Romm K, Rossberg J, Berg A, Hansen C, Andreassen O, Melle I . Assessment of social anxiety in first episode psychosis using the Liebowitz Social Anxiety scale as a self-report measure. Eur Psychiatry. 2010; 26(2):115-21. DOI: 10.1016/j.eurpsy.2010.08.014. View

19.

Bitar Z, Haddad C, Obeid S, Hallit S . Treatment satisfaction and its association with anxiety, depression and fear of COVID-19 among Lebanese inpatients with schizophrenia. Pharm Pract (Granada). 2021; 19(3):2364. PMC: 8455125. DOI: 10.18549/PharmPract.2021.3.2364. View

20.

Nyhuis A, Faries D, Ascher-Svanum H, Stauffer V, Kinon B . Predictors of switching antipsychotic medications in the treatment of schizophrenia. BMC Psychiatry. 2010; 10:75. PMC: 2955631. DOI: 10.1186/1471-244X-10-75. View